- Home
- GROW vs OVID Comparison
GROW vs OVID Comparison
Compare GROW & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- OVID
- Stock Information
- Founded
- GROW 1968
- OVID 2014
- Country
- GROW United States
- OVID United States
- Employees
- GROW N/A
- OVID N/A
- Industry
- GROW Investment Managers
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- OVID Health Care
- Exchange
- GROW Nasdaq
- OVID Nasdaq
- Market Cap
- GROW 27.4M
- OVID 24.0M
- IPO Year
- GROW N/A
- OVID 2017
- Fundamental
- Price
- GROW $2.16
- OVID $0.29
- Analyst Decision
- GROW
- OVID Strong Buy
- Analyst Count
- GROW 0
- OVID 6
- Target Price
- GROW N/A
- OVID $3.03
- AVG Volume (30 Days)
- GROW 18.6K
- OVID 381.4K
- Earning Date
- GROW 05-08-2025
- OVID 05-13-2025
- Dividend Yield
- GROW 4.19%
- OVID N/A
- EPS Growth
- GROW N/A
- OVID N/A
- EPS
- GROW 0.01
- OVID N/A
- Revenue
- GROW $8,932,000.00
- OVID $548,000.00
- Revenue This Year
- GROW N/A
- OVID N/A
- Revenue Next Year
- GROW N/A
- OVID $36.11
- P/E Ratio
- GROW $203.47
- OVID N/A
- Revenue Growth
- GROW N/A
- OVID 44.39
- 52 Week Low
- GROW $2.02
- OVID $0.24
- 52 Week High
- GROW $2.73
- OVID $3.43
- Technical
- Relative Strength Index (RSI)
- GROW 49.46
- OVID 40.05
- Support Level
- GROW $2.09
- OVID $0.28
- Resistance Level
- GROW $2.23
- OVID $0.33
- Average True Range (ATR)
- GROW 0.05
- OVID 0.03
- MACD
- GROW 0.01
- OVID 0.00
- Stochastic Oscillator
- GROW 50.00
- OVID 12.36
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.